BIOASIS BREAKING THROUGH WITH THE WORLD'S FIRST BLOOD TEST FOR ALZHEIMER'S After years of research, a small Canadian biotech company is on the verge of commercializing two 'holy-grail' technologies in the field of central nervous system (CNS) disorders. The first is the long sought-after simple blood test for diagnosing Alzheimer's disease (AD). The second is a carrier of therapeutics across the blood-brain barrier (BBB), the primary obstacle to treating many diseases including inoperable brain tumors and Parkinson's.The potential of both these technologies to deliver breakthroughs in fight against some of the worst diseases plaguing humanity today is immeasurabl Keywords: Irfan Cehajic, TechnicalBuy, Bioasis, Alzheimer's, Central Nervous System, Biotech, Blood Brain Barrier